DAVID SCHEER

Profile

First Name

: DAVID

Middle Name

:

Last Name

: SCHEER

Related Companies
Titles
Company Name
Related People
DIRECTOR
AEGERION PHARMACEUTICALS, INC.
DAVID ARKOWITZ, ALISON DE BORD, JASON FISHERMAN, PETER GARRAMBONE, ANTONIO M. GOTTO, ALISON KILEY, WILLIAM H. LEWIS, MICHELE OLLIER, CHRISTINE PELLIZZARI, WILLIAM SASIELA
DIRECTOR
TENGION INC
TIM BERTRAM, TIMOTHY BERTRAM, CARL-JOHAN DALSGAARD, A. BRIAN DAVIS, A. BRIAN DAVIS, SCOTT D. FLORA, BRENDA D GAVIN, DIANE JORKASKY, RICHARD KUNTZ, RICHARD E. KUNTZ, GARY J KURTZMAN, JOHN MICLOT, JOHN L. MICLOT, STEVEN NICHTBERGER, LORIN J RANDALL, LORIN J. RANDALL, DAVID I SCHEER, SUNITA SHETH, MARK STEJBACH
EXECUTIVE OFFICER
PLANIT IMPACT INC.
MICHAEL J. BRAY, DOMINIQUE DAVISON, CRAIG HUGHEY
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DNAMX, INC.
LISA ALDERSON, DAVID BONITA, SCOTT BRATMAN, PAUL BROWN, DANIEL DE CARVALHO, DANIEL DINIZ DE CARVALHO, ANDREW ELBARDISSI, ANNE-RENEE HARTMAN, ANNE-RENEE HARTMAN FELDMAN, PRISCILLA HUANG, MANEESH JAIN, KARLA JARVIS, ABRAHAM KOMETZ, LINDSAY MATEO, CHRISTOPHER PARKER, ROBERT WEISSKOFF, ALAN WILLIAMS
DIRECTOR
REFACTOR HEALTH, INC.
MICHAEL APKON, HARLAN KRUMHOLZ, WADE SCHULZ, PAUL ZABALETA
DIRECTOR
REVELAR BIOTHERAPEUTICS, INC.
PAUL FONTEYNE, BRETT GIROIR, GLENN MARINA, LAURENCE SMITH
EXECUTIVE OFFICER, DIRECTOR
THYRON PHARMACEUTICALS, INC.
STEPHEN BLOCH, PETER FARINA, PAUL FONTEYNE
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ADELA, INC.
LISA ALDERSON, DAVID BONITA, SCOTT BRATMAN, PAUL BROWN, DANIEL DE CARVALHO, DANIEL DINIZ DE CARVALHO, ANDREW ELBARDISSI, ANNE-RENEE HARTMAN, ANNE-RENEE HARTMAN FELDMAN, PRISCILLA HUANG, MANEESH JAIN, KARLA JARVIS, ABRAHAM KOMETZ, LINDSAY MATEO, CHRISTOPHER PARKER, ROBERT WEISSKOFF, ALAN WILLIAMS
DIRECTOR
THIRDLAW MOLECULAR, INC.
BRIAN HALAK, ERIC HEIL, CHRISTIAN SCHAFMEISTER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2026-04-10 
2025-10-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-02 
2025-07-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-06-23 
2024-07-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2024-02-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2021-07-14 
2024-02-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2023-10-10 
2023-08-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2022-05-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-04-20 
2022-02-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-04 
2021-11-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-01 
2021-09-27
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-14 
2021-09-27
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-07 
2021-03-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-17 
2018-10-17
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2018-03-20 
2018-04-02
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2018-03-20 
2013-08-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2013-06-28 
2012-10-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2012-10-02 
2010-06-28
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02 
2010-02-09
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02 
2009-07-15
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02